Member Info for bobbyaxelrod

Rough calculations/
Market cap currently around 500mn
Revenue for this year nearing 300mn. Profit c150mn
conservative 10x multiple on earnings 1.5bn
3x current value

Uncertainty about reduced demand for product with time understandable given the vaccine, but testing will be needed worldwide alongside the fact that the business will deploy capital it accrues to earn more from covid and other ventures, acquisitions and partnerships.

Forecast cash balance end of 2020 350mn

I was tempted to sell half my holding still while I had significant profits, but looking at the chart it might consolidate around 700-800 for a while, then increase with earnings rumors and reports.

All IMO

profitable company, with cash balance and fairly priced given the industry is going to grow
recurring predictable revenues
massive offering: music licenses, anti-piracy offering... men&motors
clever purchasing approach of buying some a percentage and retaining rights to buy the rest - can follow the money

As these shares in Erris Gold are privately held - will they still be held in my broker account? Or are we posted this information?

Hi all, been a holder here since 4p - originally invested purely on the basis of the gold assets, so recent developments seem like a bonus I think).

My question is how do we receive or hold the Erris Gold shares? I have not received any information from by broker, and as I understand the new gold entity won't be listed.

With HSBC being hit from all sides with the global recession, covid, Trump and China, it has really taken a beating. I think as LTH it will do great. With China posting better numbers and Biden favourite to win the election it looks like things should improve for HSBC, as well as probable dividend reinstatement.

Sales numbers, adjusted for covid, were still strong. Company paying a dividend showing it values shareholders and is also financially healthy. There will be a backlog of work plus return to additional work will lead to increased revenues given time.

Medica's position as market leader has many growth drivers most notably: not enough radiologists being trained, and the continued increases in volume and reliance on imaging within healthcare (with many drivers of this including reduced cost of imaging and also healthcare guidelines stipulating imaging as part of diagnostic processes). Ultimately this means the teleradiology gap that Medica operates in is growing, and Medica (as the UK market leader) is best placed to capitalise on filling this growing gap.

Slowly creeping there. I think the UK growth will be easier given less competition for commercial property as well. But anyone who takes the time to read through the company's investment documents will realise what good investment potential is here - the business seems extremely well run and planned out.

I noticed this company trades at less than half its NAV (based on most recent balance sheet figures) c£9m market cap versus c£20m net asset value. It's profitable with negligible debt. Why is this trading at such a discount?

well run company with all the demand drivers still present and growing in magnitude. any dips I look to continue to build my holding

I think IHC have the perfect plan for growth without compromising business health. And yes, that's a capital idea to email him!

I have also been tempted to add more here. Volume is low, but this company is doing all the right things. It's clear in its long term aims to grow revenues to greater than £100mn through targeted acquisitions.

The only negative I can stretch to lies in their long term aim to be the leader in specifically neonatal care, with most health plays being based around the growing ageing population narrative. They say they expect an increasing number of births (such as premature) requiring their services and products, but, even if this is not true, as the world gets wealthier most likely more resources per birth will be mobilised anyway, thus still creating compelling growing demand for IHC.

I love CBOX's business model, growth story and the opportunity they create for franchisees. Taking into account the expected UK growth the price still seems attractive, but growing online sales and a strengthening brand aren't. What I would love to see is some start to an international expansion, albeit unlikely in near future, but one can hope - this would send share price flying.

I'm out today 4000 sell order (that I forgot about) hit. Nice run from 1100 - don't think I would have sold if it hadn't have been triggered though

Consistent revenue growth and consistently profitable. Good cash position, with more money in inventory and receivables. Positive trading update stating an additional £5mn in revenue additional to what would otherwise be expected - but despite this P:E is currently lower that previous years and IHC trades its 52w low. Has a range of products on offer, but notably CPAP is also key in tackling covid-19 as well as growing population of patients such as those with congestive cardiac failure.

Seems to have a lot of positive aspects on which momentum can hopefully build.

Somehow my stop loss wasn't triggered - they are sneaky.
- Best case: a RNS with standard wording, a nice 6 month extension after a busy business period time might allow more time to fill the balance sheet holes and consolidate AIM listing, with an equity raise, and subsequent share price increase towards the end of the year.
- Worst case: I wont state the obvious
- What will actually happen: I think on Monday share price will find it's new level, lower than this (unlikely as the RNS gives little business information - apart from stating they already do not expect 6mn raise to be enough). Share price will drift lower on low volumes and low news, with occasional spikes, and little liquidity. If the business performs well then massive returns at some point - all it would take it would be 1 positive trading statement to send this NORTH. But ultimately I think this will remain a punt, with some successful punters, until the inevitable. GLA

Such a fast bounce back! What a share.

3 things to raise revenues: Brexit stockpiling, Christmas trading, Covid-19 related increased demand.
Last year's interim accounts it looks like a widening hole was forming in the balance sheet, albeit with some outstanding receivables - and they only run to May 2019. Hopefully the rest of year's trading did not do irreversible damage, and the high interest loan with available 20mn credit facility are enough.

Up and down all the way up. Hopefully tomorrow is good

So even thought Stobarts are plastered all over the roads, it must be this complex ownership structure that is holding the price back. I'd imagine/hope this busy period will translate to greater revenues and enough cash raised.

too early is better than not all. They probably picked up a few more 8% cheaper today...